2018
DOI: 10.3389/fnins.2018.00584
|View full text |Cite
|
Sign up to set email alerts
|

The Argus-II Retinal Prosthesis Implantation; From the Global to Local Successful Experience

Abstract: Over the past few years, visual prostheses (namely, Argus II retinal implant) and gene therapy have obtained FDA approval in treating blindness resulting from retinitis pigmentosa. Compared to gene therapy; Argus II is less costly with a demonstrated favorable outcome, though the vision is yet artificial. To obtain better results, expectation counseling and preoperative retinal assessment are critical. The global experience with Argus II has enrolled no more than 300 cases so far. The first Argus II retinal pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
32
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(32 citation statements)
references
References 30 publications
(83 reference statements)
0
32
0
Order By: Relevance
“…The Argus II device is programmed at M1 for initial programming prior to turning on the camera in order to find stimulation levels that are suitable for the patient to be set on their Video Processing Unit (VPU) [ 4 , 5 ]. During the first session, the electrodes whose resistances are too high are disabled and the electrodes that are functional and usable are determined.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…The Argus II device is programmed at M1 for initial programming prior to turning on the camera in order to find stimulation levels that are suitable for the patient to be set on their Video Processing Unit (VPU) [ 4 , 5 ]. During the first session, the electrodes whose resistances are too high are disabled and the electrodes that are functional and usable are determined.…”
Section: Methodsmentioning
confidence: 99%
“…A quick scan of the array is done using various stimulation amplitudes to determine which electrodes are able to produce a percept or phosphene. The minimum current that is needed for the patient to see a phosphene 50 % of the time is defined for each electrode [ 1 , 4 ]. The video signal from the camera is mapped to the electrical signal for individual or groups of electrodes, determining which electrodes are being stimulated and at what respective frequency.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A quick scan of the array is done using various stimulation amplitudes to determine which electrodes are able to produce a percept or phosphene. The minimum current that is needed for the patient to see a phosphene fty percent of the time is de ned for each electrode 1,4 . The video signal from the camera is mapped to the electrical signal for individual or groups of electrodes, determining which electrodes are being stimulated and at what respective frequency.…”
Section: Sensitivity Detection Thresholdmentioning
confidence: 99%
“…These values are set to the patients VPU to be used in different conditions 1 . Programming for this study included use of the "Programming Assistant" software that is designed to streamline the programming process to measure general sensitivity 1,4 . Through use of this software, the camera alignment process is simpli ed and comfort is determined under more real-world stimulation conditions 1 .…”
Section: Sensitivity Detection Thresholdmentioning
confidence: 99%